|
|
- Hemophilia: What to know about your treatment options
Dr Sridharan recommends working with a hemophilia treatment center to guide treatment and care You can find and contact regional hemophilia treatment centers through the CDC’s online directory Understanding your treatment options There are three main types of hemophilia treatment: factor replacement, non-factor replacement and gene therapy
- List of 43 Hemophilia A Medications Compared - Drugs. com
Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available
- Hemophilia Therapies - Rare Disease Advisor
Koāte ® (antihemophilic factor [human]), also known as Koāte-DVI, is a human plasma-derived FVIII indicated for the treatment and prevention of bleeding episodes in patients with hemophilia A Initially approved in the US in 1974, the processing methods have been updated over the years to make the product safer from viral contamination
- AHF (Antihemophilic Factor): Uses Side Effects - Cleveland Clinic
AHF (antihemophilic factor) is a medication that prevents or manages bleeding if you have hemophilia A This condition keeps your blood from clotting as it should so you bleed more than expected A healthcare provider will usually give you this injection in a hospital or clinic setting
- List of Treatments for Hemophilia | MyHemophiliaTeam
Jivi (Antihemophilic Factor [Recombinant] Pegylated-Aucl) Overview Jivi is a recombinant antihemophilic factor approved by the U S Food and Drug Administration (FDA) for the treatment and management of hemophilia A (congenital factor VIII [8] deficiency) in previously treated… read more
- Approved Treatments for Hemophilia – Hemophilia News Today
The primary treatment for hemophilia is replacement therapy that supplies the clotting factors to hemophilia patients who lack them Other approved treatments include bypassing agents, gene therapies, and nonfactor replacement therapies Alphanate (human antihemophilic factor von Willebrand factor complex) is a factor replacement therapy to
- Know Your Treatment Options | Novoeight® (Antihemophilic Factor . . .
When comparing your hemophilia A treatment choices, you might also consider extended half-life (EHL) Esperoct ® [antihemophilic factor (recombinant), glycopegylated-exei] We start with the existing Novoeight ® molecule and add PEGylation technology to extend the factor’s half-life
- Acquired Hemophilia Treatment Management - Medscape
Recombinant antihemophilic factor, porcine sequence Historically, porcine factor VIII has provided a good effect A porcine sequence recombinant FVIII (rpFVIII; Obizur) was approved by the US Food and Drug Administration (FDA) in 2014 for treatment of bleeding episodes in adults with acquired hemophilia
- Understanding Current Bleeding Disorder Treatments | NBDF
Non-factor replacement therapies: These products help prevent bleeding or assist in better clotting using other methods in the body besides factor replacement therapy Non-factor replacement therapies include: Emicizumab (Hemlibra) is a therapy used to treat hemophilia A, to prevent bleeding episodes in people both with and without inhibitors It is known as a factor VIII(8) mimetic because it
|
|
英文每年常用名排名
2023 年排名
2022 年排名
2021 年排名
2020 年排名
2019 年排名
2018 年排名
2017 年排名
2016 年排名
2015 年排名
2014 年排名
2013 年排名
2012 年排名
2011 年排名
2010 年排名
2009 年排名
2008 年排名
2007 年排名
2006 年排名
2005 年排名
2004 年排名
2003 年排名
2002 年排名
2001 年排名
2000 年排名
英文名字起源
希伯來
希臘
條頓
印度
拉丁
拉丁語
古英語
英格蘭
阿拉伯
法國
蓋爾
英語
匈牙利
凱爾特
西班牙
居爾特
非洲
美洲土著
挪威
德國
威爾士
斯拉夫民族
古德語
愛爾蘭
波斯
古法語
盎格魯撒克遜
意大利
蓋爾語
未知
夏威夷
中古英語
梵語
蘇格蘭
俄羅斯
土耳其
捷克
希臘;拉丁
斯干那維亞
瑞典
波蘭
烏干達
拉丁;條頓
巴斯克語
亞拉姆
亞美尼亞
斯拉夫語
斯堪地納維亞
越南
荷蘭
|